Trial intelligence / Profile preview

Liraglutide Influence on Food Reward in Healthy Volunteers

NCT01695109Phase 4Completed

Sponsor
Medical University of Vienna
Start
Nov 2010
Primary completion
Feb 2012
Modality
Peptides
Countries
1
01

Overview

A Phase 4 trial of liraglutide in obesity, type 2 diabetes mellitus (T2DM), sponsored by Medical University of Vienna. Started Nov 2010; status: completed.

02

Drugs

03

Conditions

obesitytype 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on NCT01695109.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01695109.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call